InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Mehta Vimal, CEO, Président et secrétaire. Insider active across 1 company, notably BioXcel Therapeutics, Inc.. In total, 24 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €12.4m. History available since 25 June 2021. The latest transaction was disclosed on 20 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mehta Vimal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
219 股Common StockSEC:0001104659-26-075298:0
49,758 股Common StockSEC:0001104659-26-065836:0
19,419 股@ US$1.0870.059% mcap0.1% 占其流量Common StockSEC:0001104659-26-065836:1
164 股Common StockSEC:0001104659-26-028722:0
164 股Common StockSEC:0001104659-25-121304:0
163 股Common StockSEC:0001104659-25-090518:0
219 股Common StockSEC:0001104659-25-090518:1
15,625 股Common StockSEC:0001104659-25-069703:0
163 股Common StockSEC:0001104659-25-059980:0
162 股Common StockSEC:0001104659-25-024531:0
2,610 股Common StockSEC:0001104659-24-129462:0
2,609 股Common StockSEC:0001104659-24-100751:0
2,609 股Common StockSEC:0001104659-24-072999:0
609,221 股Common StockSEC:0001104659-24-069195:0
2,610 股Common StockSEC:0001104659-24-044861:0
2,609 股Common StockSEC:0001104659-23-126924:0
2,610 股Common StockSEC:0001104659-23-101635:0
2,609 股Common StockSEC:0001104659-23-072396:0
6,500 股@ US$25.79090.6% 占其流量Common StockSEC:0001104659-23-064163:0
15,000 股Common StockSEC:0001104659-23-061539:0
30,000 股@ US$0.410.0% 占其流量Common StockSEC:0001104659-23-035711:0
10,437 股Common StockSEC:0001104659-23-033403:0
30,000 股@ US$0.410.0% 占其流量Common StockSEC:0001104659-22-128367:0
473,250 股@ US$30.828398.4% 占其流量Common StockSEC:0001104659-21-086948:0
24 条申报中的 24 条
About Mehta Vimal
Mehta Vimal is CEO, Président et secrétaire of BioXcel Therapeutics, Inc. He has 24 filings in total, and in the sampled recent filings, all linked to BioXcel Therapeutics, Inc., there were only sales for EUR 12402134 between 2021-06-29 and 2026-06-17. The modal transaction nature is Levée d'options.
